Cargando…

Changes in serum uric acid levels after allogeneic hematologic stem cell transplantation: A retrospective cohort study

BACKGROUND: Since cell turnover in the hematopoietic system constitutes a major source of uric acid (UA) production, we investigated whether hematopoietic stem cell transplantation (HSCT) is associated with significant changes in serum UA levels in patients with hematological disorders. METHODS: Pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joo, Sang Hyun, Park, Jin Kyun, Lee, Eunyoung Emily, Song, Yeong Wook, Yoon, Sung-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054253/ https://www.ncbi.nlm.nih.gov/pubmed/27722132 http://dx.doi.org/10.5045/br.2016.51.3.200

Ejemplares similares

The role of serum uric acid in the prediction of graft‐versus‐host disease in allogeneic hematopoietic stem cell transplantation
por: Ghasemi, Katayoon, et al.
Publicado: (2020)

Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders
por: Mahmoud, Hossam K., et al.
Publicado: (2015)

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies
por: Zahid, Mohammad Faizan, et al.
Publicado: (2014)

Is a cure for CML without allogeneic stem cell transplantation around the corner?
por: Sohn, Sang Kyun
Publicado: (2014)

Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies
por: Pavletic, ZS, et al.
Publicado: (1998)

Allogeneic Stem Cell Transplantation for Patients with Advanced Hematological Malignancies: Comparison of Fludarabine-based Reduced Intensity Conditioning versus Myeloablative Conditioning
por: Kim, Inho, et al.
Publicado: (2007)

Wernicke's encephalopathy following allogeneic hematopoietic stem cell transplantation
por: Choi, Yoon Ji, et al.
Publicado: (2010)

Observation of the Serum Uric Acid in Essential Hypertension
por: Kim, Yeon Ho, et al.
Publicado: (1986)

Outcomes of allogeneic stem cell transplantation for patients with hematologic diseases ≥60 years old
por: Shima, Takahiro, et al.
Publicado: (2023)

Association of FOXP3 Single Nucleotide Polymorphisms With Clinical Outcomes After Allogenic Hematopoietic Stem Cell Transplantation
por: Nam, Minjeong, et al.
Publicado: (2018)

The limited role of serum galactomannan assay in screening for invasive pulmonary aspergillosis in allogeneic stem cell transplantation recipients on micafungin prophylaxis: a retrospective study
por: Kim, Ryul, et al.
Publicado: (2017)

Allogeneic stem cell transplantation for neuroblastoma
por: Sung, Ki Woong
Publicado: (2012)

2696. Breakthrough Toxoplasmosis While on Atovaquone Prophylaxis Following Allogeneic Hematologic Stem Cell Transplantation
por: Chueng, Teresa A, et al.
Publicado: (2019)

Outcomes of two-step haploidentical allogeneic stem cell transplantation in elderly patients with hematologic malignancies
por: Bi, Xia, et al.
Publicado: (2022)

Reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for patients with myelofibrosis
por: Kim, Dong Hyun, et al.
Publicado: (2022)

Current Use of Total Body Irradiation in Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation
por: Jung, Jongheon, et al.
Publicado: (2021)

The Confirmation of Safety for the Intensified Conditioning Regimens: A Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation for Non-Remission Hematological Malignant Diseases
por: Yoshida, Shuro, et al.
Publicado: (2018)

Pre-transplant depression decreased overall survival of patients receiving allogeneic hematopoietic stem cell transplantation: a nationwide cohort study
por: Wang, Sheng-Min, et al.
Publicado: (2020)

Serum Uric Acid and Metabolic Syndrome: a Retrospective Cohort Study
por: Kim, Hun-Sung
Publicado: (2019)

Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant?
por: Park, Hyunkyung, et al.
Publicado: (2020)

Serum Uric Acid and Renal Transplantation Outcomes: At Least 3-Year Post-transplant Retrospective Multivariate Analysis
por: Zhang, Kun, et al.
Publicado: (2015)

Feasibility of Non-TBI Conditioning with Busulfan and Fludarabine for Allogeneic Stem Cell Transplantation in Lymphoid Malignancy
por: Shin, Ho Cheol, et al.
Publicado: (2012)

Association between post-transplant serum uric acid levels and kidney transplantation outcomes
por: Kim, Deok Gie, et al.
Publicado: (2018)

Certain Autoimmune Manifestations Are Associated With Distinctive Karyotypes and Outcomes in Patients With Myelodysplastic Syndrome: A Retrospective Cohort Study
por: Lee, Sang Jin, et al.
Publicado: (2016)

Survey of experts on therapeutic policies and proposals for the optimal timing for allogeneic peripheral blood stem cell transplantation in transfusion-dependent patients with myelodysplastic syndrome-refractory anemia
por: Sohn, Sang Kyun, et al.
Publicado: (2016)

P1351: CHARACTERIZING ALLOGENEIC STEM CELL TRANSPLANTATION SAFETY IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES AFTER PEMBROLIZUMAB THERAPY
por: Kuruvilla, J., et al.
Publicado: (2022)

Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
por: Rhee, Chin Kook, et al.
Publicado: (2016)

Clinical Significance of Platelet Count at day +60 After Allogeneic Peripheral Blood Stem Cell Transplantation
por: Kim, Dong Hwan, et al.
Publicado: (2006)

Lineage-specific chimerism analysis in nucleated cells, T cells and natural killer cells after myeloablative allogeneic hematopoietic stem cell transplantation
por: Goh, Ri-Young, et al.
Publicado: (2011)

Rapid cardiovascular aging following allogeneic hematopoietic cell transplantation for hematological malignancy
por: Dillon, Hayley T., et al.
Publicado: (2022)

Hematological patterns and histopathological assessment of Miniature Pigs in the experiments on human mesenchymal stem cell transplantation
por: Son, Young-Bum, et al.
Publicado: (2021)

Toxoplasma Encephalitis in an Allogeneic Hematopoietic Stem Cell Transplant Recipient in Korea
por: Park, Soo-Kyung, et al.
Publicado: (2012)

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
por: Xuan, Li, et al.
Publicado: (2012)

Very Long Term Stability of Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies
por: Levrat, Emmanuel, et al.
Publicado: (2015)

Exercise before, during, and after Hospitalization for Allogeneic Hematological Stem Cell Transplant: A Feasibility Randomized Controlled Trial
por: Santa Mina, Daniel, et al.
Publicado: (2020)

Infections in Allogeneic Stem Cell Transplantation
por: Pereira, Marcus R., et al.
Publicado: (2018)

Recent advances and current challenges in allogeneic stem cell transplantation in patients with acquired severe aplastic anemia
por: Lee, Sung-Eun, et al.
Publicado: (2018)

Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment
por: Thiel, U, et al.
Publicado: (2013)

Allogeneic stem cell transplant for myelofibrosis- A retrospective single-center study
por: Choudhary, Dharma, et al.
Publicado: (2023)

Kinetics of neutrophil engraftment in allogeneic stem cell transplantation
por: Kawajiri, Akihisa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_snfc6ua319idqe9qq4a6pqof3k